In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...